SUNITINIB for Metastases to bone: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 31 adverse event reports in the FDA FAERS database where SUNITINIB was used for Metastases to bone.
Most Reported Side Effects for SUNITINIB
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 280 | 15.7% | 44 | 36 |
| Drug ineffective | 243 | 13.6% | 50 | 66 |
| Malignant neoplasm progression | 242 | 13.6% | 80 | 32 |
| Fatigue | 132 | 7.4% | 22 | 26 |
| Diarrhoea | 129 | 7.2% | 24 | 38 |
| Osteonecrosis of jaw | 115 | 6.5% | 2 | 8 |
| Hypertension | 99 | 5.6% | 7 | 17 |
| Off label use | 99 | 5.6% | 11 | 20 |
| Thrombocytopenia | 96 | 5.4% | 21 | 35 |
| Death | 85 | 4.8% | 83 | 6 |
| Palmar-plantar erythrodysaesthesia syndrome | 84 | 4.7% | 7 | 13 |
| Neutropenia | 80 | 4.5% | 15 | 15 |
| Gastrointestinal stromal tumour | 75 | 4.2% | 25 | 8 |
| Anaemia | 74 | 4.2% | 10 | 33 |
| Nausea | 69 | 3.9% | 12 | 31 |
Other Indications for SUNITINIB
Gastrointestinal stromal tumour (297)
Metastatic renal cell carcinoma (229)
Product used for unknown indication (202)
Renal cell carcinoma (143)
Clear cell renal cell carcinoma (95)
Renal cancer (80)
Neoplasm malignant (56)
Pancreatic neuroendocrine tumour (37)
Pancreatic neuroendocrine tumour metastatic (29)
Metastases to liver (27)
Other Drugs Used for Metastases to bone
DENOSUMAB (5,083)
ZOLEDRONIC ACID (3,177)
RADIUM RA-223 DICHLORIDE (1,501)
PALBOCICLIB (556)
CABOZANTINIB S-MALATE (514)
ENZALUTAMIDE (439)
XGEVA (412)
RIBOCICLIB (383)
LETROZOLE (263)
CARBOPLATIN (254)